BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu S, Zeng M, Feng G, Wu H. Platinum Nanoparticles As A Therapeutic Agent Against Dextran Sodium Sulfate-Induced Colitis In Mice. Int J Nanomedicine 2019;14:8361-78. [PMID: 31749615 DOI: 10.2147/IJN.S210655] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang CJ, Byun MJ, Kim S, Park W, Park HH, Kim T, Lee JS, Park CG. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sathiyaraj G, Vinosha M, Sangeetha D, Manikandakrishnan M, Palanisamy S, Sonaimuthu M, Manikandan R, You S, Prabhu NM. Bio-directed synthesis of Pt-nanoparticles from aqueous extract of red algae Halymenia dilatata and their biomedical applications. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2021;618:126434. [DOI: 10.1016/j.colsurfa.2021.126434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Brinkmann BW, Singhal A, Sevink GJA, Neeft L, Vijver MG, Peijnenburg WJGM. Predicted Adsorption Affinity for Enteric Microbial Metabolites to Metal and Carbon Nanomaterials. J Chem Inf Model 2022. [PMID: 35876029 DOI: 10.1021/acs.jcim.2c00492] [Reference Citation Analysis]
4 Yang J, Zhou J, Zhao Y, Zhu L, Luo G, Ge B. Hollow CeO2 with ROS-Scavenging Activity to Alleviate Colitis in Mice. Int J Nanomedicine 2021;16:6889-904. [PMID: 34675513 DOI: 10.2147/IJN.S317261] [Reference Citation Analysis]
5 Han R, Xiao Y, Bai Q, Jonathan Choi CH. Self-therapeutic metal-based nanoparticles for treating inflammatory diseases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.009] [Reference Citation Analysis]
6 Wang LM, Wang YT, Yang WX. Engineered nanomaterials induce alterations in biological barriers: focus on paracellular permeability. Nanomedicine (Lond) 2021;16:2725-41. [PMID: 34870452 DOI: 10.2217/nnm-2021-0165] [Reference Citation Analysis]
7 Ma Y, Liu X, Liu D, Yin Z, Yang X, Zeng M. Oyster (Crassostrea gigas) Polysaccharide Ameliorates High-Fat-Diet-Induced Oxidative Stress and Inflammation in the Liver via the Bile Acid-FXR-AMPKα Pathway. J Agric Food Chem 2022. [PMID: 35797440 DOI: 10.1021/acs.jafc.2c02490] [Reference Citation Analysis]
8 Hu L, Zhao Y, Xu H. Trojan horse in the intestine: A review on the biotoxicity of microplastics combined environmental contaminants. J Hazard Mater 2022;439:129652. [PMID: 35901632 DOI: 10.1016/j.jhazmat.2022.129652] [Reference Citation Analysis]
9 Feng G, Han K, Yang Q, Feng W, Guo J, Wang J, Yang X. Interaction of Pyrogallol-Containing Polyphenols with Mucin Reinforces Intestinal Mucus Barrier Properties. J Agric Food Chem . [DOI: 10.1021/acs.jafc.2c03564] [Reference Citation Analysis]
10 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wang H, Cui Z, Wang X, Sun S, Zhang D, Fu C. Therapeutic Applications of Nanozymes in Chronic Inflammatory Diseases. Biomed Res Int 2021;2021:9980127. [PMID: 34423042 DOI: 10.1155/2021/9980127] [Reference Citation Analysis]
12 Hao W, Cha R, Wang M, Zhang P, Jiang X. Impact of nanomaterials on the intestinal mucosal barrier and its application in treating intestinal diseases. Nanoscale Horiz 2021;7:6-30. [PMID: 34889349 DOI: 10.1039/d1nh00315a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Xie D, Jiang L, Lin Y, Liu Z. Antioxidant activity of selenium-enriched Chrysomyia megacephala (Fabricius) larvae powder and its impact on intestinal microflora in D-galactose induced aging mice. BMC Complement Med Ther 2020;20:264. [PMID: 32854685 DOI: 10.1186/s12906-020-03058-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Hartwig O, Shetab Boushehri MA, Shalaby KS, Loretz B, Lamprecht A, Lehr CM. Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Adv Drug Deliv Rev 2021;175:113828. [PMID: 34157320 DOI: 10.1016/j.addr.2021.113828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Cameron SJ, Sheng J, Hosseinian F, Willmore WG. Nanoparticle Effects on Stress Response Pathways and Nanoparticle–Protein Interactions. IJMS 2022;23:7962. [DOI: 10.3390/ijms23147962] [Reference Citation Analysis]